Form D — Capital Rx, Inc.
0001782959-25-000002 · filed 2025-09-26
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $232,885,143
- Total sold
- $230,820,898
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Capital Rx, Inc.
- CIK
- 1782959
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 228 PARK AVENUE S.
NEW YORK, NY 10003 - Phone
- 855-538-8897
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
A. J. Loiacono · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Ryan Kelly · DirectorNew York, NY Find on LinkedIn ↗
-
Lenard Marcus · DirectorNew York, NY Find on LinkedIn ↗
-
Kevin Hill · DirectorNew York, NY Find on LinkedIn ↗
-
Jared Kesselheim · DirectorNew York, NY Find on LinkedIn ↗
-
Robert Mittendorff · DirectorNew York, NY Find on LinkedIn ↗
-
Daniel Delmastro · DirectorNew York, NY Find on LinkedIn ↗
-
Mark Kandrysawtz · DirectorNew York, NY Find on LinkedIn ↗
-
Mostafa Kamal · DirectorNew York, NY Find on LinkedIn ↗
-
Holly Maloney · DirectorNew York, NY Find on LinkedIn ↗
View original on SEC EDGAR.